Capital raised by Barricade Therapeutics
1 Form D filing · first filed May 2026 · Fort Worth, TX
Chief Executive Officer
Signatory on Barricade Therapeutics's Form D filings · $100K raised across 1
Neil Thapar is on file as Chief Executive Officer at Barricade Therapeutics in Fort Worth, TX. Barricade Therapeutics has 1 Form D filing on record, $100K raised in total. Neil Thapar appears as a signatory on the company's filings.
LinkedIn profileNo other people are on file at Barricade Therapeutics. Form D filings only name the signatory and the company's executive officers.
An investigational oral small-molecule EBP inhibitor designed to target the genetic drivers of colorectal cancer progression in APC-mutant patients.
